Review




Structured Review

Novartis car t-cells
Car T Cells, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+t+cells/nct04283006-3-9-9
Average 90 stars, based on 1 article reviews
car t-cells - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

other:

Article Title: The 49 th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O009-O172).
Article Snippet: S COLLECTION The 49 Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Oral Sessions (O009-O172) Bone Marrow Transplantation (2023) 58:20–152; https://doi.org/10.1038/s41409-023-02055-8 © Springer Nature Limited 2023 23 – 26 April, 2023 ● Hybrid Meeting Copyright: Modified and published with permission from https://www.ebmt.org/annual-meeting Sponsorship Statement: Publication of this supplement is sponsored by the European Society for Blood and Marrow Transplantation.. All content was reviewed and approved by the EBMT Committee, which held full responsibility for the abstract selections.. 19 Acute Leukaemia

Article Title: Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Article Snippet: The therapeutic benefit of CAR T-cells in patients with newly-diagnosed National Cancer Institute high-risk BCP-ALL with persistent minimal residual disease after two cycles of chemotherapy [39] (induction and consolidation) is currently being investigated in the CASSIOPEIA (Novartis) trial, given the documented poor clinical outcomes of this population with 5-year event-free survival of 39% [40].

Article Title: Cytokine Storm
Article Snippet: PCT/US2013/050283: EPITOPE SPREADING ASSOCIATED WITH CAR T-cells ✔ ✔ ✔ Confidential This IP has been licensed by the Trustees of the University of Pennsylvania to one or more of Novartis, Tmunity Therapeutics, Inc. or Carisma Therapeutics.

Article Title: A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies
Article Snippet: On August 30, 2017, the US FDA first approved Novartis CAR T-cells for the treatment of acute lymphocytic leukemia.



Similar Products

90
Novartis car t-cells
Car T Cells, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+t+cells/nct04283006-3-9-9
Average 90 stars, based on 1 article reviews
car t-cells - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

99
TaKaRa αm car transfected lenti x 293 t cells
αm Car Transfected Lenti X 293 T Cells, supplied by TaKaRa, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/Lenti-X+293T+Cell+Line/10__1007_slash_s00262___026___04557___y-74-8-15
Average 99 stars, based on 1 article reviews
αm car transfected lenti x 293 t cells - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

99
Sartorius AG mcherry car t cells
A Schematic for ( B – F ) where <t>CAR</t> <t>T</t> cells and Eμ-myc cells were cocultured with unMac, imMac, M1-like macrophages, or without macrophages. Created in BioRender. Stone, M. ( https://BioRender.com/xpmm6k3 ) B CAR T cell death at 48 h was assessed by 7-aminoactinomycin D (7-AAD) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). C DNA replication of CAR T cells at 42 h was measured by bromodeoxyuridine (BrdU) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment). D CAR T cell expansion was measured over 48 h by a live cell analysis system. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. E Total CAR expression levels in CAR T cells at 48 h were assessed via flow cytometry. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. F Surface CAR expression levels in CAR T cells at 48 h were detected by staining single-chain variable fragments (scFv) of CAR with protein L and analyzed via flow cytometry ( n = 4 technical replicates from a single experiment). G Schematic for ( H – J ) where CAR T cells were isolated after initial coculture with Eμ-myc cells and with unMac or imMac or without macrophages (No Mac) for 48 h and subsequently cocultured with fresh Eμ-myc cells. H , I Levels of IFN-γ and TNF-α in coculture supernatants of CAR T cells and Eμ-myc cells at 36 h were analyzed by an automated enzyme-linked immunosorbent assay (ELISA) ( n = 4 technical replicates from a single experiment). J Lysis of Eμ-myc cells by CAR T cells at 36 h was assessed using a bioluminescence assay. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. All data are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( D , E , J ). Exact P values are provided in the Source Data file. **, P < 0.01; ***, P < 0.001; ### , P < 0.001; #### , P <0.0001; $, P < 0.05; BM bone marrow, MFI mean fluorescence intensity, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.
Mcherry Car T Cells, supplied by Sartorius AG, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/Live+Cell+Analysis+Instruments/pmc13627683-408-3-18
Average 99 stars, based on 1 article reviews
mcherry car t cells - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier

86
Bristol Myers car t cell therapy lisocabtagene maraleucel liso cel
A Schematic for ( B – F ) where <t>CAR</t> <t>T</t> cells and Eμ-myc cells were cocultured with unMac, imMac, M1-like macrophages, or without macrophages. Created in BioRender. Stone, M. ( https://BioRender.com/xpmm6k3 ) B CAR T cell death at 48 h was assessed by 7-aminoactinomycin D (7-AAD) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). C DNA replication of CAR T cells at 42 h was measured by bromodeoxyuridine (BrdU) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment). D CAR T cell expansion was measured over 48 h by a live cell analysis system. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. E Total CAR expression levels in CAR T cells at 48 h were assessed via flow cytometry. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. F Surface CAR expression levels in CAR T cells at 48 h were detected by staining single-chain variable fragments (scFv) of CAR with protein L and analyzed via flow cytometry ( n = 4 technical replicates from a single experiment). G Schematic for ( H – J ) where CAR T cells were isolated after initial coculture with Eμ-myc cells and with unMac or imMac or without macrophages (No Mac) for 48 h and subsequently cocultured with fresh Eμ-myc cells. H , I Levels of IFN-γ and TNF-α in coculture supernatants of CAR T cells and Eμ-myc cells at 36 h were analyzed by an automated enzyme-linked immunosorbent assay (ELISA) ( n = 4 technical replicates from a single experiment). J Lysis of Eμ-myc cells by CAR T cells at 36 h was assessed using a bioluminescence assay. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. All data are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( D , E , J ). Exact P values are provided in the Source Data file. **, P < 0.01; ***, P < 0.001; ### , P < 0.001; #### , P <0.0001; $, P < 0.05; BM bone marrow, MFI mean fluorescence intensity, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.
Car T Cell Therapy Lisocabtagene Maraleucel Liso Cel, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/lisocabtagene+maraleucel/pm42278639-159-0-15
Average 86 stars, based on 1 article reviews
car t cell therapy lisocabtagene maraleucel liso cel - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Hamad Medical Corporation car t cell therapy
A Schematic for ( B – F ) where <t>CAR</t> <t>T</t> cells and Eμ-myc cells were cocultured with unMac, imMac, M1-like macrophages, or without macrophages. Created in BioRender. Stone, M. ( https://BioRender.com/xpmm6k3 ) B CAR T cell death at 48 h was assessed by 7-aminoactinomycin D (7-AAD) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). C DNA replication of CAR T cells at 42 h was measured by bromodeoxyuridine (BrdU) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment). D CAR T cell expansion was measured over 48 h by a live cell analysis system. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. E Total CAR expression levels in CAR T cells at 48 h were assessed via flow cytometry. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. F Surface CAR expression levels in CAR T cells at 48 h were detected by staining single-chain variable fragments (scFv) of CAR with protein L and analyzed via flow cytometry ( n = 4 technical replicates from a single experiment). G Schematic for ( H – J ) where CAR T cells were isolated after initial coculture with Eμ-myc cells and with unMac or imMac or without macrophages (No Mac) for 48 h and subsequently cocultured with fresh Eμ-myc cells. H , I Levels of IFN-γ and TNF-α in coculture supernatants of CAR T cells and Eμ-myc cells at 36 h were analyzed by an automated enzyme-linked immunosorbent assay (ELISA) ( n = 4 technical replicates from a single experiment). J Lysis of Eμ-myc cells by CAR T cells at 36 h was assessed using a bioluminescence assay. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. All data are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( D , E , J ). Exact P values are provided in the Source Data file. **, P < 0.01; ***, P < 0.001; ### , P < 0.001; #### , P <0.0001; $, P < 0.05; BM bone marrow, MFI mean fluorescence intensity, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.
Car T Cell Therapy, supplied by Hamad Medical Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+cell+t+therapy/pm42265975-12-7-38
Average 86 stars, based on 1 article reviews
car t cell therapy - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Autolus Inc antigen receptor car t cells
A Schematic for ( B – F ) where <t>CAR</t> <t>T</t> cells and Eμ-myc cells were cocultured with unMac, imMac, M1-like macrophages, or without macrophages. Created in BioRender. Stone, M. ( https://BioRender.com/xpmm6k3 ) B CAR T cell death at 48 h was assessed by 7-aminoactinomycin D (7-AAD) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). C DNA replication of CAR T cells at 42 h was measured by bromodeoxyuridine (BrdU) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment). D CAR T cell expansion was measured over 48 h by a live cell analysis system. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. E Total CAR expression levels in CAR T cells at 48 h were assessed via flow cytometry. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. F Surface CAR expression levels in CAR T cells at 48 h were detected by staining single-chain variable fragments (scFv) of CAR with protein L and analyzed via flow cytometry ( n = 4 technical replicates from a single experiment). G Schematic for ( H – J ) where CAR T cells were isolated after initial coculture with Eμ-myc cells and with unMac or imMac or without macrophages (No Mac) for 48 h and subsequently cocultured with fresh Eμ-myc cells. H , I Levels of IFN-γ and TNF-α in coculture supernatants of CAR T cells and Eμ-myc cells at 36 h were analyzed by an automated enzyme-linked immunosorbent assay (ELISA) ( n = 4 technical replicates from a single experiment). J Lysis of Eμ-myc cells by CAR T cells at 36 h was assessed using a bioluminescence assay. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. All data are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( D , E , J ). Exact P values are provided in the Source Data file. **, P < 0.01; ***, P < 0.001; ### , P < 0.001; #### , P <0.0001; $, P < 0.05; BM bone marrow, MFI mean fluorescence intensity, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.
Antigen Receptor Car T Cells, supplied by Autolus Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/antigen+car+cells+receptor+t/pm42272105-13-27-11
Average 86 stars, based on 1 article reviews
antigen receptor car t cells - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Novartis car t cell treatment
A Schematic for ( B – F ) where <t>CAR</t> <t>T</t> cells and Eμ-myc cells were cocultured with unMac, imMac, M1-like macrophages, or without macrophages. Created in BioRender. Stone, M. ( https://BioRender.com/xpmm6k3 ) B CAR T cell death at 48 h was assessed by 7-aminoactinomycin D (7-AAD) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). C DNA replication of CAR T cells at 42 h was measured by bromodeoxyuridine (BrdU) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment). D CAR T cell expansion was measured over 48 h by a live cell analysis system. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. E Total CAR expression levels in CAR T cells at 48 h were assessed via flow cytometry. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. F Surface CAR expression levels in CAR T cells at 48 h were detected by staining single-chain variable fragments (scFv) of CAR with protein L and analyzed via flow cytometry ( n = 4 technical replicates from a single experiment). G Schematic for ( H – J ) where CAR T cells were isolated after initial coculture with Eμ-myc cells and with unMac or imMac or without macrophages (No Mac) for 48 h and subsequently cocultured with fresh Eμ-myc cells. H , I Levels of IFN-γ and TNF-α in coculture supernatants of CAR T cells and Eμ-myc cells at 36 h were analyzed by an automated enzyme-linked immunosorbent assay (ELISA) ( n = 4 technical replicates from a single experiment). J Lysis of Eμ-myc cells by CAR T cells at 36 h was assessed using a bioluminescence assay. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. All data are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( D , E , J ). Exact P values are provided in the Source Data file. **, P < 0.01; ***, P < 0.001; ### , P < 0.001; #### , P <0.0001; $, P < 0.05; BM bone marrow, MFI mean fluorescence intensity, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.
Car T Cell Treatment, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+cell+t+therapy/pm42250386-42-18-21
Average 86 stars, based on 1 article reviews
car t cell treatment - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Bristol Myers car t cell technologies
Relapse and toxicity outcomes after <t>CD19-CAR.</t> (A) Cumulative incidence of relapse in the iBM (n = 21; green), EMD (n = 36; red), and CNS (n = 251; blue) cohorts, calculated using the Kaplan-Meier method. (B) <t>Post-CAR</t> <t>T-cell</t> relapse phenotype was assessed by flow cytometry and was reported as either CD19 + , CD19 − , lineage switch, or unknown. Relapse occurred in 134 patients (EMD n = 7; CNS n = 21; iBM n = 106). There were no statistical differences in the phenotypes among the cohorts. (C) Incidence of CRS in the different patient cohorts. Each pie chart represents 1 of the 3 cohorts as indicated. Displayed are patients with no CRS (blue), grade 1 to 2 CRS (gold), and grade 3 to 5 CRS (beige). CRS was graded by the reporting institution and included 126 of 308 (40.9%) cases graded according to the Lee criteria, 156 of 308 (50.6%) cases graded according to the University of Pennsylvania criteria, and 26 of 308 (8.4%) cases graded according to the American Society for Transplantation and Cellular Therapy guidelines. (D) The percentage of patients who developed neurotoxicity, as diagnosed by reporting institution, in the cohorts is indicated on the x-axis. (E) Reported reason for post-CAR HSCT in each individual cohort. Other encompasses 4 patients in the BM alone cohort who proceeded to transplant because of next-generation sequencing positivity in the absence of flow-detectable disease (n = 2), persistent BM aplasia (n = 1), and relapse with unknown phenotype characterized by the development of a scalp chloroma by day 28 after infusion (n = 1).
Car T Cell Technologies, supplied by Bristol Myers, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+cells+t/pmc13195614-220-16-11
Average 86 stars, based on 1 article reviews
car t cell technologies - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Fisher Scientific car t cell manufacture
Relapse and toxicity outcomes after <t>CD19-CAR.</t> (A) Cumulative incidence of relapse in the iBM (n = 21; green), EMD (n = 36; red), and CNS (n = 251; blue) cohorts, calculated using the Kaplan-Meier method. (B) <t>Post-CAR</t> <t>T-cell</t> relapse phenotype was assessed by flow cytometry and was reported as either CD19 + , CD19 − , lineage switch, or unknown. Relapse occurred in 134 patients (EMD n = 7; CNS n = 21; iBM n = 106). There were no statistical differences in the phenotypes among the cohorts. (C) Incidence of CRS in the different patient cohorts. Each pie chart represents 1 of the 3 cohorts as indicated. Displayed are patients with no CRS (blue), grade 1 to 2 CRS (gold), and grade 3 to 5 CRS (beige). CRS was graded by the reporting institution and included 126 of 308 (40.9%) cases graded according to the Lee criteria, 156 of 308 (50.6%) cases graded according to the University of Pennsylvania criteria, and 26 of 308 (8.4%) cases graded according to the American Society for Transplantation and Cellular Therapy guidelines. (D) The percentage of patients who developed neurotoxicity, as diagnosed by reporting institution, in the cohorts is indicated on the x-axis. (E) Reported reason for post-CAR HSCT in each individual cohort. Other encompasses 4 patients in the BM alone cohort who proceeded to transplant because of next-generation sequencing positivity in the absence of flow-detectable disease (n = 2), persistent BM aplasia (n = 1), and relapse with unknown phenotype characterized by the development of a scalp chloroma by day 28 after infusion (n = 1).
Car T Cell Manufacture, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/car+cell+manufacture+t/pm42166352-54-74-69
Average 86 stars, based on 1 article reviews
car t cell manufacture - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

86
Olon Ricerca Bioscience acute myeloid leukemia car t cell therapy martina pigazzi1 2
Relapse and toxicity outcomes after <t>CD19-CAR.</t> (A) Cumulative incidence of relapse in the iBM (n = 21; green), EMD (n = 36; red), and CNS (n = 251; blue) cohorts, calculated using the Kaplan-Meier method. (B) <t>Post-CAR</t> <t>T-cell</t> relapse phenotype was assessed by flow cytometry and was reported as either CD19 + , CD19 − , lineage switch, or unknown. Relapse occurred in 134 patients (EMD n = 7; CNS n = 21; iBM n = 106). There were no statistical differences in the phenotypes among the cohorts. (C) Incidence of CRS in the different patient cohorts. Each pie chart represents 1 of the 3 cohorts as indicated. Displayed are patients with no CRS (blue), grade 1 to 2 CRS (gold), and grade 3 to 5 CRS (beige). CRS was graded by the reporting institution and included 126 of 308 (40.9%) cases graded according to the Lee criteria, 156 of 308 (50.6%) cases graded according to the University of Pennsylvania criteria, and 26 of 308 (8.4%) cases graded according to the American Society for Transplantation and Cellular Therapy guidelines. (D) The percentage of patients who developed neurotoxicity, as diagnosed by reporting institution, in the cohorts is indicated on the x-axis. (E) Reported reason for post-CAR HSCT in each individual cohort. Other encompasses 4 patients in the BM alone cohort who proceeded to transplant because of next-generation sequencing positivity in the absence of flow-detectable disease (n = 2), persistent BM aplasia (n = 1), and relapse with unknown phenotype characterized by the development of a scalp chloroma by day 28 after infusion (n = 1).
Acute Myeloid Leukemia Car T Cell Therapy Martina Pigazzi1 2, supplied by Olon Ricerca Bioscience, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/car+t-cells/2+acute+car+cell+leukemia+martina+myeloid+pigazzi1+t+therapy/pm42098093-22-31-90
Average 86 stars, based on 1 article reviews
acute myeloid leukemia car t cell therapy martina pigazzi1 2 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


A Schematic for ( B – F ) where CAR T cells and Eμ-myc cells were cocultured with unMac, imMac, M1-like macrophages, or without macrophages. Created in BioRender. Stone, M. ( https://BioRender.com/xpmm6k3 ) B CAR T cell death at 48 h was assessed by 7-aminoactinomycin D (7-AAD) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). C DNA replication of CAR T cells at 42 h was measured by bromodeoxyuridine (BrdU) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment). D CAR T cell expansion was measured over 48 h by a live cell analysis system. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. E Total CAR expression levels in CAR T cells at 48 h were assessed via flow cytometry. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. F Surface CAR expression levels in CAR T cells at 48 h were detected by staining single-chain variable fragments (scFv) of CAR with protein L and analyzed via flow cytometry ( n = 4 technical replicates from a single experiment). G Schematic for ( H – J ) where CAR T cells were isolated after initial coculture with Eμ-myc cells and with unMac or imMac or without macrophages (No Mac) for 48 h and subsequently cocultured with fresh Eμ-myc cells. H , I Levels of IFN-γ and TNF-α in coculture supernatants of CAR T cells and Eμ-myc cells at 36 h were analyzed by an automated enzyme-linked immunosorbent assay (ELISA) ( n = 4 technical replicates from a single experiment). J Lysis of Eμ-myc cells by CAR T cells at 36 h was assessed using a bioluminescence assay. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. All data are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( D , E , J ). Exact P values are provided in the Source Data file. **, P < 0.01; ***, P < 0.001; ### , P < 0.001; #### , P <0.0001; $, P < 0.05; BM bone marrow, MFI mean fluorescence intensity, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: IFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma

doi: 10.1038/s41467-026-76972-9

Figure Lengend Snippet: A Schematic for ( B – F ) where CAR T cells and Eμ-myc cells were cocultured with unMac, imMac, M1-like macrophages, or without macrophages. Created in BioRender. Stone, M. ( https://BioRender.com/xpmm6k3 ) B CAR T cell death at 48 h was assessed by 7-aminoactinomycin D (7-AAD) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). C DNA replication of CAR T cells at 42 h was measured by bromodeoxyuridine (BrdU) incorporation via flow cytometry ( n = 4 technical replicates from a single experiment). D CAR T cell expansion was measured over 48 h by a live cell analysis system. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. E Total CAR expression levels in CAR T cells at 48 h were assessed via flow cytometry. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. F Surface CAR expression levels in CAR T cells at 48 h were detected by staining single-chain variable fragments (scFv) of CAR with protein L and analyzed via flow cytometry ( n = 4 technical replicates from a single experiment). G Schematic for ( H – J ) where CAR T cells were isolated after initial coculture with Eμ-myc cells and with unMac or imMac or without macrophages (No Mac) for 48 h and subsequently cocultured with fresh Eμ-myc cells. H , I Levels of IFN-γ and TNF-α in coculture supernatants of CAR T cells and Eμ-myc cells at 36 h were analyzed by an automated enzyme-linked immunosorbent assay (ELISA) ( n = 4 technical replicates from a single experiment). J Lysis of Eμ-myc cells by CAR T cells at 36 h was assessed using a bioluminescence assay. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition. All data are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( D , E , J ). Exact P values are provided in the Source Data file. **, P < 0.01; ***, P < 0.001; ### , P < 0.001; #### , P <0.0001; $, P < 0.05; BM bone marrow, MFI mean fluorescence intensity, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Article Snippet: The expansion of mCherry + CAR T cells was determined by an IncuCyte S3 live cell analysis system (Essen Bioscience).

Techniques: Flow Cytometry, BrdU Incorporation Assay, Cell Analysis, Control, Expressing, Staining, Isolation, Automated, Enzyme-linked Immunosorbent Assay, Lysis, ATP Bioluminescent Assay, Fluorescence

A Schematic for ( B – F ) where CAR T cells and Eμ-myc cells were cocultured with unMac or imMac or without macrophages (No Mac) for 24 h. Coculture supernatants were analyzed by global metabolomics using LC-MS. B , C Quantification of relative abundance of metabolites in the supernatants derived from cocultures containing imMac versus No Mac ( B ) or unMac ( C ) ( n = 3 technical replicates from a single experiment). D – F Arginine, ornithine, and citrulline levels in the supernatants of coculture groups ( n = 3 technical replicates from a single experiment). The data were normalized to the mean value of the no-macrophage control condition. G Flow cytometry analysis of expression of ARG-1 and iNOS in unMac or imMac cocultured with Eμ-myc cells in the presence or absence of CAR T cells at 24 h. Data are from n = 3 independent experiments. H NO levels in the supernatants derived from cocultures of CAR T cells and Eμ-myc cells with unMac or imMac or without macrophages at 48 h were analyzed by Griess assay. Data are from n = 3 independent experiments. Data in ( D – H ) are presented as mean ± SD. Statistical significance was determined by unpaired two-sided Student’s t tests ( G ) or one-way ANOVA with Bonferroni correction for multiple comparisons ( H ). Exact P values are provided in the Source Data file. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; ns not significant, FC fold change, LC-MS liquid chromatography-mass spectrometry, iNOS inducible nitric oxide synthase, ARG-1 arginase-1, NO nitric oxide. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: IFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma

doi: 10.1038/s41467-026-76972-9

Figure Lengend Snippet: A Schematic for ( B – F ) where CAR T cells and Eμ-myc cells were cocultured with unMac or imMac or without macrophages (No Mac) for 24 h. Coculture supernatants were analyzed by global metabolomics using LC-MS. B , C Quantification of relative abundance of metabolites in the supernatants derived from cocultures containing imMac versus No Mac ( B ) or unMac ( C ) ( n = 3 technical replicates from a single experiment). D – F Arginine, ornithine, and citrulline levels in the supernatants of coculture groups ( n = 3 technical replicates from a single experiment). The data were normalized to the mean value of the no-macrophage control condition. G Flow cytometry analysis of expression of ARG-1 and iNOS in unMac or imMac cocultured with Eμ-myc cells in the presence or absence of CAR T cells at 24 h. Data are from n = 3 independent experiments. H NO levels in the supernatants derived from cocultures of CAR T cells and Eμ-myc cells with unMac or imMac or without macrophages at 48 h were analyzed by Griess assay. Data are from n = 3 independent experiments. Data in ( D – H ) are presented as mean ± SD. Statistical significance was determined by unpaired two-sided Student’s t tests ( G ) or one-way ANOVA with Bonferroni correction for multiple comparisons ( H ). Exact P values are provided in the Source Data file. **, P < 0.01; ***, P < 0.001; ****, P < 0.0001; ns not significant, FC fold change, LC-MS liquid chromatography-mass spectrometry, iNOS inducible nitric oxide synthase, ARG-1 arginase-1, NO nitric oxide. Source data are provided as a Source Data file.

Article Snippet: The expansion of mCherry + CAR T cells was determined by an IncuCyte S3 live cell analysis system (Essen Bioscience).

Techniques: Liquid Chromatography with Mass Spectroscopy, Derivative Assay, Control, Flow Cytometry, Analysis, Expressing, Griess Assay, Liquid Chromatography, Mass Spectrometry

A CAR T cells and Eμ-myc cells were cocultured with unMac, imMac or no macrophages, +/- L-NIL (50 μM). CAR T cell expansion was measured over 48 h using live cell analysis. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. B – D After 48 h coculture described in ( A ), isolated CAR T cells were cocultured with fresh Eμ-myc cells. B Target cell lysis was assessed by luciferase assay at 24 h ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). C , D IFN-γ and TNF-α in coculture supernatants at 36 h were analyzed by ELISA ( n = 4 technical replicates from a single experiment). E CAR T cells and Eμ-myc cells were cocultured with WT or iNOS −/− unMac or imMac or without macrophages. CAR T cell expansion was measured over 48 h by a live cell analysis ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). F After 48 h of coculture described in ( E ), isolated CAR T cells were cocultured with fresh Eμ-myc cells and target cell lysis was assessed at 36 h ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). G CAR T cells and Eμ-myc cells were cocultured with NCX-4016 or 0.01% DMSO (Veh). CAR T cell expansion was measured over 48 h by a live cell analysis. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding +Veh control condition at each time point. H CAR T cells were cocultured with Eμ-myc cells +/- peroxynitrite (PNT). CAR T cell expansion was measured over 48 h by a live cell analysis. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-treatment control condition at each time point. I After 48 h of initial coculture described in G-H, isolated CAR T cells were cocultured with fresh Eμ-myc cells, and target cell lysis was assessed at 24 h ( n = 4 technical replicates from a single experiment). J CAR T cells and Eμ-myc cells were cocultured with or without imMac +/- carboxyl-PTIO (c-PTIO). CAR T cell expansion was measured over 48 h by live cell analysis. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. All data are presented as mean ± SD. Statistical significance was determined by unpaired two-sided Student’s t tests ( A , G , H , J ). Exact P values are provided in the Source Data file. *, P < 0.05; **, P < 0.01; ***, P < 0.001; exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: IFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma

doi: 10.1038/s41467-026-76972-9

Figure Lengend Snippet: A CAR T cells and Eμ-myc cells were cocultured with unMac, imMac or no macrophages, +/- L-NIL (50 μM). CAR T cell expansion was measured over 48 h using live cell analysis. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. B – D After 48 h coculture described in ( A ), isolated CAR T cells were cocultured with fresh Eμ-myc cells. B Target cell lysis was assessed by luciferase assay at 24 h ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). C , D IFN-γ and TNF-α in coculture supernatants at 36 h were analyzed by ELISA ( n = 4 technical replicates from a single experiment). E CAR T cells and Eμ-myc cells were cocultured with WT or iNOS −/− unMac or imMac or without macrophages. CAR T cell expansion was measured over 48 h by a live cell analysis ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). F After 48 h of coculture described in ( E ), isolated CAR T cells were cocultured with fresh Eμ-myc cells and target cell lysis was assessed at 36 h ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). G CAR T cells and Eμ-myc cells were cocultured with NCX-4016 or 0.01% DMSO (Veh). CAR T cell expansion was measured over 48 h by a live cell analysis. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding +Veh control condition at each time point. H CAR T cells were cocultured with Eμ-myc cells +/- peroxynitrite (PNT). CAR T cell expansion was measured over 48 h by a live cell analysis. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-treatment control condition at each time point. I After 48 h of initial coculture described in G-H, isolated CAR T cells were cocultured with fresh Eμ-myc cells, and target cell lysis was assessed at 24 h ( n = 4 technical replicates from a single experiment). J CAR T cells and Eμ-myc cells were cocultured with or without imMac +/- carboxyl-PTIO (c-PTIO). CAR T cell expansion was measured over 48 h by live cell analysis. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the corresponding no-macrophage control condition at each time point. All data are presented as mean ± SD. Statistical significance was determined by unpaired two-sided Student’s t tests ( A , G , H , J ). Exact P values are provided in the Source Data file. *, P < 0.05; **, P < 0.01; ***, P < 0.001; exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Article Snippet: The expansion of mCherry + CAR T cells was determined by an IncuCyte S3 live cell analysis system (Essen Bioscience).

Techniques: Cell Analysis, Control, Isolation, Lysis, Luciferase, Enzyme-linked Immunosorbent Assay

A – C CAR T cells and Eμ-myc cells were cocultured with unMac or imMac in the presence of anti-IFN-γ (10 μg/mL) or IsoCon (10 μg/mL). (A) Expression of ARG-1 and iNOS in unMac or imMac was analyzed at 24 h via flow cytometry ( n = 3 technical replicates from a single experiment, repeated 2 times with similar results). B NO levels in coculture supernatants at 44 h were analyzed by Griess assay. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the +imMac+IsoCon control. ( C ) CAR T cell expansion was measured over 48 h by a live cell analysis system ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). D – F After initial coculture of CAR T cells and Eμ-myc cells with unMac or imMac in the presence of anti-IFN-γ (10 μg/mL) or IsoCon (10 μg/mL) for 48 h, isolated CAR T cells were cocultured with fresh Eμ-myc cells. D Luciferase-based lysis of Eμ-myc cells by CAR T cells was assessed at 24 h ( n = 4 technical replicates from a single experiment). E , F Levels of IFN-γ and TNF-α in the coculture supernatants at 24 h were analyzed by ELISA ( n = 4 technical replicates from a single experiment). G Schematic for ( H ) where WT or IFN-γ −/− CAR T cells were cocultured with Eμ-myc cells in the presence of unMac or imMac. After coculture for 16 h, scRNA-seq was performed on T cells. H Pathway enrichment analysis of differentially expressed genes in CAR T cells from cocultures of WT CAR T cells and imMac, compared to those from WT CAR T cells and unMac or IFN-γ −/− CAR T cells and imMac cocultures ( n = 2 technical replicates from a single experiment). Data in ( A – F ) are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( B ). Exact P values are provided in the Source Data file. ***, P < 0.001; ****, P < 0.0001; IsoCon isotype control, NO nitric oxide, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: IFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma

doi: 10.1038/s41467-026-76972-9

Figure Lengend Snippet: A – C CAR T cells and Eμ-myc cells were cocultured with unMac or imMac in the presence of anti-IFN-γ (10 μg/mL) or IsoCon (10 μg/mL). (A) Expression of ARG-1 and iNOS in unMac or imMac was analyzed at 24 h via flow cytometry ( n = 3 technical replicates from a single experiment, repeated 2 times with similar results). B NO levels in coculture supernatants at 44 h were analyzed by Griess assay. Data are from n = 3 independent experiments. Within each independent experiment, technical replicates were averaged, and values were normalized to the +imMac+IsoCon control. ( C ) CAR T cell expansion was measured over 48 h by a live cell analysis system ( n = 4 technical replicates from a single experiment, repeated 2 times with similar results). D – F After initial coculture of CAR T cells and Eμ-myc cells with unMac or imMac in the presence of anti-IFN-γ (10 μg/mL) or IsoCon (10 μg/mL) for 48 h, isolated CAR T cells were cocultured with fresh Eμ-myc cells. D Luciferase-based lysis of Eμ-myc cells by CAR T cells was assessed at 24 h ( n = 4 technical replicates from a single experiment). E , F Levels of IFN-γ and TNF-α in the coculture supernatants at 24 h were analyzed by ELISA ( n = 4 technical replicates from a single experiment). G Schematic for ( H ) where WT or IFN-γ −/− CAR T cells were cocultured with Eμ-myc cells in the presence of unMac or imMac. After coculture for 16 h, scRNA-seq was performed on T cells. H Pathway enrichment analysis of differentially expressed genes in CAR T cells from cocultures of WT CAR T cells and imMac, compared to those from WT CAR T cells and unMac or IFN-γ −/− CAR T cells and imMac cocultures ( n = 2 technical replicates from a single experiment). Data in ( A – F ) are presented as mean ± SD. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( B ). Exact P values are provided in the Source Data file. ***, P < 0.001; ****, P < 0.0001; IsoCon isotype control, NO nitric oxide, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Article Snippet: The expansion of mCherry + CAR T cells was determined by an IncuCyte S3 live cell analysis system (Essen Bioscience).

Techniques: Expressing, Flow Cytometry, Griess Assay, Control, Cell Analysis, Isolation, Luciferase, Lysis, Enzyme-linked Immunosorbent Assay, Analysis

CAR T cells and Eμ-myc cells were cocultured with unMac, imMac or without macrophages (No Mac), +/- L-NIL (50 μM). After coculture for 48 h, proteomics was performed on T cells. A Experimental design. B Principal component analysis (PCA) plot of proteomics data showing distinct clustering of samples ( n = 3 technical replicates from a single experiment). C Pathway enrichment analysis of differentially expressed proteins (DEPs) in CAR T cells cocultured with imMac versus No Mac, unMac, or imMac+L-NIL (50 μM) ( n = 3 technical replicates from a single experiment). D – F The p53 and MYC pathway DEPs in CAR T cells cocultured with imMac versus No Mac ( D ), unMac ( E ), or imMac+L-NIL treatment ( F ) ( n = 3 technical replicates from a single experiment). G DEPs in the p53 pathway ( n = 3 technical replicates from a single experiment). H DEPs in MYC target proteins ( n = 3 technical replicates from a single experiment). Exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: IFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma

doi: 10.1038/s41467-026-76972-9

Figure Lengend Snippet: CAR T cells and Eμ-myc cells were cocultured with unMac, imMac or without macrophages (No Mac), +/- L-NIL (50 μM). After coculture for 48 h, proteomics was performed on T cells. A Experimental design. B Principal component analysis (PCA) plot of proteomics data showing distinct clustering of samples ( n = 3 technical replicates from a single experiment). C Pathway enrichment analysis of differentially expressed proteins (DEPs) in CAR T cells cocultured with imMac versus No Mac, unMac, or imMac+L-NIL (50 μM) ( n = 3 technical replicates from a single experiment). D – F The p53 and MYC pathway DEPs in CAR T cells cocultured with imMac versus No Mac ( D ), unMac ( E ), or imMac+L-NIL treatment ( F ) ( n = 3 technical replicates from a single experiment). G DEPs in the p53 pathway ( n = 3 technical replicates from a single experiment). H DEPs in MYC target proteins ( n = 3 technical replicates from a single experiment). Exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Article Snippet: The expansion of mCherry + CAR T cells was determined by an IncuCyte S3 live cell analysis system (Essen Bioscience).

Techniques: Analysis, Isolation

A – L CAR T cells and Eμ-myc cells were cocultured with unMac or imMac or without macrophages (No Mac), +/- L-NIL (50 μM). After coculture for 48 h, global metabolomics was performed on T cells. Quantification of relative abundance of metabolites in CAR T cells derived from cocultures with imMac versus No Mac ( A ), unMac ( B ), or imMac+L-NIL treatment ( C ) ( n = 4 technical replicates from a single experiment). D Schematic depicting altered metabolites associated with glycolysis pathway and TCA cycle. ( E – L ) Levels of F1,6BP, G3P, DHAP, citrate, aconitate, succinate, malate, and itaconate ( n = 4 technical replicates from a single experiment). The data were normalized to the mean value of CAR T cells derived from cocultures without macrophages and L-NIL treatment. M CAR T cells were cocultured with Eμ-myc cells in the presence or absence of 4-OI. CAR T cell expansion was measured over 48 h by a live cell analysis system (1928z CAR T ( + Veh), n = 4; +4-OI (500 µM), n = 3; +4-OI (1 mM), n = 4; +4-OI (2 mM), n = 4; technical replicates from a single experiment, repeated 2 times with similar results). N CAR T cells and Eμ-myc cells were cocultured with imMac or without macrophages (No Mac), +/- L-NIL (50 μM). After coculture for 48 h, seahorse assay was performed on CAR T cells ( n = 6 technical replicates from a single experiment). ECAR was measured in response to glucose (Glc), ATP synthase inhibitor (Oligo), or hexokinase II inhibitor (2-DG). OCR was measured in response to Oligo, mitochondrial oxidative phosphorylation uncoupler (FCCP), or electron transport chain complex I/III inhibitor (Rot/AA). Data in ( E – N ) are presented as mean ± SD. F1,6BP fructose 1,6-bisphosphate, G3P glyceraldehyde 3-phosphate, DHAP dihydroxyacetone phosphate, 4-OI 4-octyl itaconate, ECAR extracellular acidification rate, OCR oxygen consumption rate, Oligo oligomycin A, 2-DG 2-deoxy-D-glucose, FCCP carbonyl cyanide p-trifluoromethoxyphenylhydrazone, Rot/AA rotenone/antimycin A, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: IFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma

doi: 10.1038/s41467-026-76972-9

Figure Lengend Snippet: A – L CAR T cells and Eμ-myc cells were cocultured with unMac or imMac or without macrophages (No Mac), +/- L-NIL (50 μM). After coculture for 48 h, global metabolomics was performed on T cells. Quantification of relative abundance of metabolites in CAR T cells derived from cocultures with imMac versus No Mac ( A ), unMac ( B ), or imMac+L-NIL treatment ( C ) ( n = 4 technical replicates from a single experiment). D Schematic depicting altered metabolites associated with glycolysis pathway and TCA cycle. ( E – L ) Levels of F1,6BP, G3P, DHAP, citrate, aconitate, succinate, malate, and itaconate ( n = 4 technical replicates from a single experiment). The data were normalized to the mean value of CAR T cells derived from cocultures without macrophages and L-NIL treatment. M CAR T cells were cocultured with Eμ-myc cells in the presence or absence of 4-OI. CAR T cell expansion was measured over 48 h by a live cell analysis system (1928z CAR T ( + Veh), n = 4; +4-OI (500 µM), n = 3; +4-OI (1 mM), n = 4; +4-OI (2 mM), n = 4; technical replicates from a single experiment, repeated 2 times with similar results). N CAR T cells and Eμ-myc cells were cocultured with imMac or without macrophages (No Mac), +/- L-NIL (50 μM). After coculture for 48 h, seahorse assay was performed on CAR T cells ( n = 6 technical replicates from a single experiment). ECAR was measured in response to glucose (Glc), ATP synthase inhibitor (Oligo), or hexokinase II inhibitor (2-DG). OCR was measured in response to Oligo, mitochondrial oxidative phosphorylation uncoupler (FCCP), or electron transport chain complex I/III inhibitor (Rot/AA). Data in ( E – N ) are presented as mean ± SD. F1,6BP fructose 1,6-bisphosphate, G3P glyceraldehyde 3-phosphate, DHAP dihydroxyacetone phosphate, 4-OI 4-octyl itaconate, ECAR extracellular acidification rate, OCR oxygen consumption rate, Oligo oligomycin A, 2-DG 2-deoxy-D-glucose, FCCP carbonyl cyanide p-trifluoromethoxyphenylhydrazone, Rot/AA rotenone/antimycin A, exp exposed CAR T cells isolated from prior coculture. Source data are provided as a Source Data file.

Article Snippet: The expansion of mCherry + CAR T cells was determined by an IncuCyte S3 live cell analysis system (Essen Bioscience).

Techniques: Derivative Assay, Cell Analysis, Phospho-proteomics, Isolation

A Experimental settings for ( B – E ) where Eμ-myc cells were intraperitoneally injected into Rag1 −/− mice. Seven days later, WT 1928z, IFN-γ −/− 1928z, or WT 19dz CAR T cells were transferred into mice. Peritoneal lavage cells were obtained 24–40 h after CAR T cell transfer. B – D Flow cytometry analysis of iNOS + cells among CD11b + F4/80 + macrophages ( B ), ARG-1 + cells among CD11b + F4/80 + macrophages ( C ), and CD11b + F4/80 + macrophages among CD45 + cells ( D ) at 24 h after CAR T cell transfer ( n = 6 mice/group). E CD11b + peritoneal myeloid cells were obtained 40 h following WT 1928z CAR T cell transfer. CD11b + cells were then ex vivo cocultured with fresh antigen-naïve CAR T cells and Eμ-myc cells in the presence or absence of L-NIL (50 μM) (coculture ratio, 1:1:1 = CD11b + cell:CAR T:Eμ-myc cell). Expansion of CAR T cells was measured over 48 h by a live cell analysis system (technical replicates from a single experiment, +Veh, n = 4; +L-NIL, n = 4; +CD11b + cells+Veh, n = 5; + CD11b + cells+L-NIL, n = 5). ( F ) Experimental settings for (G). G Percentage of survival of tumor-bearing mice treated with WT 19dz or WT 1928z CAR T cells receiving L-NIL or PBS (vehicle). Results are from two pooled independent experiments (PBS, n = 12 mice; L-NIL, n = 12 mice; 19dz CAR T + PBS, n = 11 mice; 19dz CAR T + L-NIL, n = 12 mice; 1928z+PBS, n = 28 mice; 1928z+L-NIL, n = 34 mice). H Percentage of iNOS + cells among CD45 + CD3 - CD20 - CD56 - CD11b + CD14 + monocytes in pre-lymphodepletion leukapheresis (DR, 19 patients; NDR, 32 patients). I Human CAR T cells were cocultured with Raji cells in the presence of human monocyte-derived unpolarized macrophages (unMac; n = 4 technical replicates from 1 human donor), IL-4, IL-10, IL-13-activated macrophages (imMac; n = 4 technical replicates from 1 human donor) or macrophages activated with serum from patients in complete remission (CR) at 3 months post-treatment or from non-responders (NR) (CR, 3 patients; NR, 7 patients). CAR T cell expansion was measured over 48 h by a live cell analysis system. Area under the curve (AUC) values were compared. Data in ( B – D ) are presented as mean ± SEM and ( E , I ) are presented as mean ± SD. For the box plot in ( H ), the center line represents the median, the bounds of the box indicate the 25th and 75th percentiles, and the whiskers extend to the minimum and maximum values, with all individual data points shown. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( B – D ), unpaired two-sided Student’s t tests ( I ), two-sided log-rank Mantel-Cox test between the 1928z CAR T + PBS and 1928z CAR T + L-NIL groups ( G ), or two-sided Mann-Whitney U test ( H ). Exact P values are provided in the Source Data file. *, P < 0.05. Source data are provided as a Source Data file.

Journal: Nature Communications

Article Title: IFN-γ-driven iNOS induction in macrophages mediates CAR T cell resistance in B cell lymphoma

doi: 10.1038/s41467-026-76972-9

Figure Lengend Snippet: A Experimental settings for ( B – E ) where Eμ-myc cells were intraperitoneally injected into Rag1 −/− mice. Seven days later, WT 1928z, IFN-γ −/− 1928z, or WT 19dz CAR T cells were transferred into mice. Peritoneal lavage cells were obtained 24–40 h after CAR T cell transfer. B – D Flow cytometry analysis of iNOS + cells among CD11b + F4/80 + macrophages ( B ), ARG-1 + cells among CD11b + F4/80 + macrophages ( C ), and CD11b + F4/80 + macrophages among CD45 + cells ( D ) at 24 h after CAR T cell transfer ( n = 6 mice/group). E CD11b + peritoneal myeloid cells were obtained 40 h following WT 1928z CAR T cell transfer. CD11b + cells were then ex vivo cocultured with fresh antigen-naïve CAR T cells and Eμ-myc cells in the presence or absence of L-NIL (50 μM) (coculture ratio, 1:1:1 = CD11b + cell:CAR T:Eμ-myc cell). Expansion of CAR T cells was measured over 48 h by a live cell analysis system (technical replicates from a single experiment, +Veh, n = 4; +L-NIL, n = 4; +CD11b + cells+Veh, n = 5; + CD11b + cells+L-NIL, n = 5). ( F ) Experimental settings for (G). G Percentage of survival of tumor-bearing mice treated with WT 19dz or WT 1928z CAR T cells receiving L-NIL or PBS (vehicle). Results are from two pooled independent experiments (PBS, n = 12 mice; L-NIL, n = 12 mice; 19dz CAR T + PBS, n = 11 mice; 19dz CAR T + L-NIL, n = 12 mice; 1928z+PBS, n = 28 mice; 1928z+L-NIL, n = 34 mice). H Percentage of iNOS + cells among CD45 + CD3 - CD20 - CD56 - CD11b + CD14 + monocytes in pre-lymphodepletion leukapheresis (DR, 19 patients; NDR, 32 patients). I Human CAR T cells were cocultured with Raji cells in the presence of human monocyte-derived unpolarized macrophages (unMac; n = 4 technical replicates from 1 human donor), IL-4, IL-10, IL-13-activated macrophages (imMac; n = 4 technical replicates from 1 human donor) or macrophages activated with serum from patients in complete remission (CR) at 3 months post-treatment or from non-responders (NR) (CR, 3 patients; NR, 7 patients). CAR T cell expansion was measured over 48 h by a live cell analysis system. Area under the curve (AUC) values were compared. Data in ( B – D ) are presented as mean ± SEM and ( E , I ) are presented as mean ± SD. For the box plot in ( H ), the center line represents the median, the bounds of the box indicate the 25th and 75th percentiles, and the whiskers extend to the minimum and maximum values, with all individual data points shown. Statistical significance was determined by one-way ANOVA with Bonferroni correction for multiple comparisons ( B – D ), unpaired two-sided Student’s t tests ( I ), two-sided log-rank Mantel-Cox test between the 1928z CAR T + PBS and 1928z CAR T + L-NIL groups ( G ), or two-sided Mann-Whitney U test ( H ). Exact P values are provided in the Source Data file. *, P < 0.05. Source data are provided as a Source Data file.

Article Snippet: The expansion of mCherry + CAR T cells was determined by an IncuCyte S3 live cell analysis system (Essen Bioscience).

Techniques: Injection, Flow Cytometry, Analysis, Ex Vivo, Cell Analysis, Derivative Assay, MANN-WHITNEY

Relapse and toxicity outcomes after CD19-CAR. (A) Cumulative incidence of relapse in the iBM (n = 21; green), EMD (n = 36; red), and CNS (n = 251; blue) cohorts, calculated using the Kaplan-Meier method. (B) Post-CAR T-cell relapse phenotype was assessed by flow cytometry and was reported as either CD19 + , CD19 − , lineage switch, or unknown. Relapse occurred in 134 patients (EMD n = 7; CNS n = 21; iBM n = 106). There were no statistical differences in the phenotypes among the cohorts. (C) Incidence of CRS in the different patient cohorts. Each pie chart represents 1 of the 3 cohorts as indicated. Displayed are patients with no CRS (blue), grade 1 to 2 CRS (gold), and grade 3 to 5 CRS (beige). CRS was graded by the reporting institution and included 126 of 308 (40.9%) cases graded according to the Lee criteria, 156 of 308 (50.6%) cases graded according to the University of Pennsylvania criteria, and 26 of 308 (8.4%) cases graded according to the American Society for Transplantation and Cellular Therapy guidelines. (D) The percentage of patients who developed neurotoxicity, as diagnosed by reporting institution, in the cohorts is indicated on the x-axis. (E) Reported reason for post-CAR HSCT in each individual cohort. Other encompasses 4 patients in the BM alone cohort who proceeded to transplant because of next-generation sequencing positivity in the absence of flow-detectable disease (n = 2), persistent BM aplasia (n = 1), and relapse with unknown phenotype characterized by the development of a scalp chloroma by day 28 after infusion (n = 1).

Journal: Blood Advances

Article Title: CD19 CAR T-cell outcomes in relapsed/refractory extramedullary B-ALL: a multisite, retrospective cohort review

doi: 10.1182/bloodadvances.2025018604

Figure Lengend Snippet: Relapse and toxicity outcomes after CD19-CAR. (A) Cumulative incidence of relapse in the iBM (n = 21; green), EMD (n = 36; red), and CNS (n = 251; blue) cohorts, calculated using the Kaplan-Meier method. (B) Post-CAR T-cell relapse phenotype was assessed by flow cytometry and was reported as either CD19 + , CD19 − , lineage switch, or unknown. Relapse occurred in 134 patients (EMD n = 7; CNS n = 21; iBM n = 106). There were no statistical differences in the phenotypes among the cohorts. (C) Incidence of CRS in the different patient cohorts. Each pie chart represents 1 of the 3 cohorts as indicated. Displayed are patients with no CRS (blue), grade 1 to 2 CRS (gold), and grade 3 to 5 CRS (beige). CRS was graded by the reporting institution and included 126 of 308 (40.9%) cases graded according to the Lee criteria, 156 of 308 (50.6%) cases graded according to the University of Pennsylvania criteria, and 26 of 308 (8.4%) cases graded according to the American Society for Transplantation and Cellular Therapy guidelines. (D) The percentage of patients who developed neurotoxicity, as diagnosed by reporting institution, in the cohorts is indicated on the x-axis. (E) Reported reason for post-CAR HSCT in each individual cohort. Other encompasses 4 patients in the BM alone cohort who proceeded to transplant because of next-generation sequencing positivity in the absence of flow-detectable disease (n = 2), persistent BM aplasia (n = 1), and relapse with unknown phenotype characterized by the development of a scalp chloroma by day 28 after infusion (n = 1).

Article Snippet: R.A.G. reports a consulting relationship with Moonlight Bio; and royalties from Bristol Myers Squibb related to CAR T-cell technologies.

Techniques: Flow Cytometry, Transplantation Assay, Next-Generation Sequencing